Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
| Autor: | Namer, M *, Soler-Michel, P, Turpin, F, Chinet-Charrot, P, de Gislain, C, Pouillart, P, Delozier, T, Luporsi, E, Etienne, P.L, Schraub, S, Eymard, J.C, Serin, D, Ganem, G, Calais, G, Maillart, P, Colin, P, Trillet-Lenoir, V, Prevost, G, Tigaud, D, Clavère, P, Marti, P, Romieu, G, Wendling, J.L |
|---|---|
| Zdroj: | In European Journal of Cancer June 2001 37(9):1132-1140 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect